Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Argen X SE | ARGX | Nov 13, 2024 | 569.60 | +2.04 |
Ascencio Sca | ASCE | Nov 13, 2024 | 45.40 | -0.44 |
Ascencio Sca | ASC | Nov 13, 2024 | 50.90 | 0.00 |
ASIT biotech SA | ASIT | Nov 13, 2024 | 0.23 | 0.00 |
Assicurazioni Generali SpA | GEN | Nov 13, 2024 | 19.50 | 0.00 |
Atenor | ATEB | Nov 13, 2024 | 4.28 | -0.47 |
AVANTIUM | AVTX | Nov 13, 2024 | 2.25 | -1.53 |
Azelis Group NV | AZE | Nov 13, 2024 | 18.73 | -0.69 |
Balta Group N.V. | BALTA | Nov 13, 2024 | 1.36 | 0.00 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Nov 13, 2024 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Nov 13, 2024 | 3.58 | 0.00 |
Banimmo SA | BANI | Nov 13, 2024 | 2.90 | 0.00 |
Banque Nationale de Belgique | BNB | Nov 13, 2024 | 409.00 | -0.97 |
Barco NV | BAR | Nov 13, 2024 | 11.04 | +1.47 |
Basilix | BAS | Nov 13, 2024 | 24.60 | 0.00 |
Beaulieu Av Certificates | BEAB | Nov 13, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Nov 13, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Nov 13, 2024 | 4 213.02 | +0.18 |
Belreca - Belgian Resources and Capital Company | BELR | Nov 13, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Nov 13, 2024 | 1.50 | 0.00 |
Belysse Group N.V. | BELYS | Nov 13, 2024 | 0.80 | +0.63 |
Biocartis Group NV | BCART | Nov 13, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Nov 13, 2024 | 0.01 | +4.62 |
Biotalys | BTLS | Nov 13, 2024 | 2.96 | -1.00 |
Boeing | BOEI | Nov 13, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Nov 13, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Nov 13, 2024 | 2.10 | +0.48 |
Brederode S.A. | BREB | Nov 13, 2024 | 105.80 | +0.38 |
Campine nv | CAMB | Nov 13, 2024 | 87.00 | +1.16 |
Candela Invest | CAND | Nov 13, 2024 | 1.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.